Joint and Soft tissues injections: Ultrasound Guided

Joint and Soft tissues injections: Ultrasound Guided

Cortisone injections as one of the most effective ways to treat swollen painful joints. Cortisone has been used to successfully treat arthritis in various joints with very minimal side effects.

Joint Fluid injections or Lubricating injections; We also administer Euflexxa, Supartz and Synvisc injections as a joint lubricant to treat osteoarthritis.

Homeopathic Injections: We also administer Homeopathic injections Traumeel and Zeel into the joints for pain relief and increase ROM . Also helpful as trigger point injections to relieve pain and stiffness in the upper and low back regions.

PRP ( Platelet Rich Plasma Injections ) and Stem Cell Injections:

The popularity of Platelet Rich Plasma (PRP) treatments among patients for Arthritis conditions has exploded in recent years as patients are now realizing the long-term and permanent benefits of this procedure. Platelet Rich Plasma (PRP) Training is the perfect complement to other injectible procedures (i.e.cortison injections Trumeel and Joint pain relief techniques ) and can be easily done in a clinic practice setting.
PRP therapies allow for the separation of a patient’s blood through a variety of harvesting techniques to extract a concentration of autologous platelets (2.5x – 9.0x). These platelets when activated release adhesive glycoproteins (fibrin, fibronectin, and vitronectin) and various growth factors forming a fibrin mesh under the tissue. The growth factors and/or cytokines released when the concentrated autologous platelets are activated in soft tissue include:

  • Transforming growth factor beta (TGFβ) – cell division and stem cell attraction
  • Connective tissue growth factor (wound healing)
  • Insulin-like growth factor I & II (ILGF)
  • Vascular endothelial growth factor (organ regeneration)
  • Epidermal growth factor (EGF)
  • Interleuken 8
  • Fibroblast growth factor (wound healing)
  • Keratinocyte growth factor (wound healing)

Platelet Rich Plasma releases healing proteins to boost the body natural healing process.

Once these proteins and growth factors bind to the cellular receptors of synovial joint cartilage skin tissue or tissue (fibroblasts, endothelial cells, and osteoblasts) at the injection point, they activate a variety of intercellular events which help mediate:

  • Angiogenesis
  • Migration of stem cells to the injection area
  • New Cell proliferation
  • Production of extracellular matrix proteins

Regeneration occurs within the tissues and fibrils ensues, growth and tissue repair will continue for up to (5) weeks after the injections. The result is promotion of local tissue growth and repair of damaged tissue that is permanent. Contrary to other solutions for joint pain relief. PRP is natural (non-synthetic) and eliminates changes or reaction

What are the Pros and Cons of PRP ?

  • Platelet-rich plasma is autologous, meaning it comes from the patient’s body, so it is natural and the injections carry few risks.
  • Other treatments for mild to moderate osteoarthritis can be unreliable or vary from person to person, and

Patients should keep in mind that PRP is not a cure-all, and it may be best used in combination with nonsurgical treatments and lifestyle changes, such as physical therapy, weight loss, bracing, and NSAIDs.

One study, published in 2013, involved 78 patients with osteoarthritis in both knees (156 knees). Each knee received one of three treatments: 1 PRP injection, 2 PRP injections, or 1 placebo saline injection. Researchers evaluated the subjects’ knees 6 weeks, 3 months, and 6 months after injection. Researchers found:

  • Knees treated with 1 or 2 PRP injections saw a reduction in pain and stiffness as well as improvement in knee function at 6 weeks and 3 months.
  • At the 6-month mark positive results declined, though pain and function were still better than before PRP treatment.
  • The group that received placebo injections saw a small increase in pain and stiffness and a decrease in knee function.

The platelet-rich plasma used in this clinical study had 3 times the platelet concentration of normal blood and had been filtered to remove white blood cells.